Starling Oncology Inc. – Filings and Transcripts

NASDAQ: STLN
Share price (8/28/26): $6.17
Market cap (8/28/26): $629 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Shelf registration – amended

Shelf registration

Shelf registration

Exempt offering of securities

Ownership Filter

News Filter

Material Definitive Agreement, New Financial Obligation or Off-Balance Sheet Arrangement, Financial Statements or Exhibits

Reports Second Quarter 2026 Financial Results and Updates Full-Year 2026 Guidance

The Oncology Institute Rebrands as Starling Oncology

The Oncology Institute Completes Strategic Refinancing With OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening Its Balance Sheet, and Improving Liquidity

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness